Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
Status:
Suspended
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this pilot study is to investigate the safety and efficacy of etanercept
(Enbrel™; Amgen) for the treatment of an acute gout attack will be non-inferior to
triamcinolone acetonide an FDA approved drug to treat acute gout attacks.